meta_pixel
Tapesearch Logo
Log in
The Treatment

John Elliott, men's clothing designer

The Treatment

KCRW

Arts

4.6639 Ratings

🗓️ 4 October 2017

⏱️ 29 minutes

🧾️ Download transcript

Summary

Men's clothing designer John Elliott joins Elvis Mitchell to discuss making his mark with the "Villain" sweatshirt.

Transcript

Click on a timestamp to play from that location

0:00.0

From KCRW Santa Monica and KCRW.com, it's The Treatment.

0:14.3

Welcome to The Treatment. I'm Elvis Mitchell. In less than 10 years, my guest, John

0:18.8

Elliott is blown up in the world of fashion.

0:21.6

I think, more importantly, in the world of style, you sort of take the cooler D.C. and ethnicies

0:27.0

and sort of move into a more adult thing.

0:29.7

That kind of energy.

0:30.7

That's what John brings to.

0:31.6

I'm wearing his jeans right now.

0:32.8

In fact, I picked these up in San Francisco and I hate.

0:35.3

This guy just went, oh, you're wearing Visrael.

0:36.9

I'm coming. I got something for you.

0:37.8

I said, I walked past this guy's story.

0:39.5

He went, come in there.

0:40.1

I got something for you.

0:41.2

And that's how I found out about you like three years ago.

0:43.2

Wow.

0:44.3

And I guess the best way I put this in terms of your shoes, apparently John Elliott knows Bo

0:49.9

better than Bo. He wrote a letter to Nike when he was a kid telling what they need to do with Bo Jackson.

0:55.4

I was that he just should concentrate on one sport.

0:57.7

But that's another conversation all together.

0:59.9

First of all, John, thanks so much for being here.

1:01.4

It's a tremendous honor.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from KCRW, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of KCRW and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.